Risk factor
Very high price volatility
Profitability factor
Very weak growth
About
Humasis Co. Ltd. is a South Korean company, established in 2000 and based in Anyang, that focuses on the development, manufacturing, and global distribution of in-vitro diagnostic products. These diagnostic tools are designed to detect various markers, including those for cardiac health, fertility hormones, infectious diseases, tumor indicators, and cotinine, and are suitable for use in both home and laboratory settings. Their offerings include consumer-friendly self-tests for pregnancy and ovulation, the Hubi-Quan Pro – an integrated device that quickly provides quantifiable results from membrane-based lateral flow immunochromatographic assays – and a broad range of other rapid diagnostic kits.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is trading at neutral levels on P/FCF